Source: Health Products Regulatory Authority (IE) Revision Year: 2019 Publisher: CIS bio international, R.N.306 Saclay B.P. 32, F 91192, Gif-sur-Yvette, Cedex, France
PULMOCIS 2 mg kit for radiopharmaceutical preparation.
Pharmaceutical Form |
---|
Kit for radiopharmaceutical preparation. White powder in pellet form. |
Each vial contains 2 mg macroaggregated human albumin (macrosalb).
The macroaggregates number per vial is ranging between 2 × 106 and 4 × 106. In the labelled product the particle size distribution is as follows: more than 95 % of the particles are between 10 and 100 micrometers. No macroaggregates has a size larger than 150 micrometer.
Produced from human serum albumin of human donors.
The radionuclide is not part of the kit.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Technetium ⁹⁹ᵐTc macrosalb |
Technetium ⁹⁹ᵐTc macrosalb is for diagnostic use only. It is used for pulmonary perfusion scintigraphy and radionuclide venography. When administered in usual doses, technetium [99mTc] macrosalb injection shows no pharmacodynamic effects detectable clinically or/and analytically. |
List of Excipients |
---|
Human albumin |
15mL, colourless, Ph. Eur. type I, drawn glass vials, closed with rubber stoppers and aluminium capsules.
Pack size: 5 multidose vials.
CIS bio international, R.N.306 Saclay B.P. 32, F 91192, Gif-sur-Yvette, Cedex, France
PA0677/003/001
Date of first authorisation: 19 October 2001
Date of last renewal: 19 October 2006
Drug | Countries | |
---|---|---|
PULMOCIS | Austria, Estonia, France, Hong Kong, Croatia, Ireland, Malta, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.